Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,004 | 4 | N/A | 497 | N/A |
| Inventories | 253 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 293 |
| TOTAL | $1,312 | $148 | $81 | $1,098 | $293 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 19,901 | 299,084 | 0 |
| TOTAL | $N/A | $N/A | $19,901 | $299,084 | $N/A |
| Total Assets | $1,312 | $148 | $19,982 | $300,182 | $293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,791 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,368 | 310 | 391 | 303 | 0 |
| Accrued Expenses | 1,009 | N/A | N/A | N/A | 55 |
| Other current liabilities | 41 | 111 | N/A | N/A | N/A |
| TOTAL | $7,593 | $1,688 | $403 | $303 | $294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 96 | 0 | 19,901 | 309,817 | 0 |
| TOTAL | $96 | $N/A | $19,901 | $309,817 | $N/A |
| Total Liabilities | $7,689 | $1,688 | $20,305 | $310,120 | $294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,024 | 1,223 | 225 | 898 | N/A |
| Common Shares | 0 | 0 | 1 | 1 | 1 |
| Retained earnings | -27,258 | -2,777 | -11,288 | -9,939 | -26 |
| TOTAL | $-6,376 | $-1,540 | $-322 | $-9,938 | $-1 |
| Total Liabilities And Equity | $1,312 | $148 | $19,982 | $300,182 | $293 |